Summary

The global market for Recombinant Limulus and Recombinant Factor C Reagent was estimated to be worth US$ 33.87 million in 2024 and is forecast to a readjusted size of US$ 106 million by 2031 with a CAGR of 16.9% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Recombinant Limulus and Recombinant Factor C Reagent cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Recombinant Limulus Amebocyte Lysate (rCR) is a genetically engineered quantitative bacterial endotoxin test. This test is independent of horseshoe crab blood resources, thus meeting sustainability goals. It fully mimics the enzyme-linked reaction of natural Limulus Amebocyte Lysate (LAL), including Factor C, Factor B, and procoagulant. It is the only endotoxin test reagent that utilizes the same enzyme-linked reaction as natural Limulus Amebocyte Lysate (LAL) while eliminating the cross-reaction with 1,3-β-D-glucan that can cause false-positive results.

Recombinant Factor C (rFC) is the first component of the in vitro recombinant Limulus Amebocyte Lysate coagulation cascade: Factor C. Activated Factor C directly cleaves a fluorescent substrate, generating a signal that is detected by a fluorescence microplate reader. Compared to natural Limulus Amebocyte Lysate (LAL), the recombinant Factor C method utilizes only one reaction mechanism.
Global 5 largest manufacturers of Recombinant Limulus and Recombinant Factor C Reagent are Lonza, Biomerieux, Associates of Cape Cod (ACC), FUJIFILM Wako and Xiamen Bioendo Technology, which make up about 30%. Among them, Lonza is the leader with about 40% market share. North America is the largest market, with a share about 46%, followed by Europe and China, with share about 35% and 7%. In terms of product type, recombinant factor C occupy the largest share of the total market, about 77%. And in terms of product application, the largest application is Pharmaceutical, followed by Medical Devices.

This report aims to provide a comprehensive presentation of the global market for Recombinant Limulus and Recombinant Factor C Reagent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Recombinant Limulus and Recombinant Factor C Reagent by region & country, by Type, and by Application.
The Recombinant Limulus and Recombinant Factor C Reagent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Limulus and Recombinant Factor C Reagent.

Market Segmentation
By Company
Lonza
Biomerieux
Associates of Cape Cod (ACC)
FUJIFILM Wako
Xiamen Bioendo Technology
Rhino Bio
Segment by Type
Recombinant Limulus Reagent
Recombinant Factor C
Segment by Application
Pharmaceutical
Medical Devices
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Recombinant Limulus and Recombinant Factor C Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Recombinant Limulus and Recombinant Factor C Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Recombinant Limulus and Recombinant Factor C Reagent in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Recombinant Limulus and Recombinant Factor C Reagent Product Introduction
1.2 Global Recombinant Limulus and Recombinant Factor C Reagent Market Size Forecast
1.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value (2020-2031)
1.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume (2020-2031)
1.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Price (2020-2031)
1.3 Recombinant Limulus and Recombinant Factor C Reagent Market Trends & Drivers
1.3.1 Recombinant Limulus and Recombinant Factor C Reagent Industry Trends
1.3.2 Recombinant Limulus and Recombinant Factor C Reagent Market Drivers & Opportunity
1.3.3 Recombinant Limulus and Recombinant Factor C Reagent Market Challenges
1.3.4 Recombinant Limulus and Recombinant Factor C Reagent Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Players Revenue Ranking (2024)
2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Revenue by Company (2020-2025)
2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Players Sales Volume Ranking (2024)
2.4 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Company Players (2020-2025)
2.5 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Company (2020-2025)
2.6 Key Manufacturers Recombinant Limulus and Recombinant Factor C Reagent Manufacturing Base and Headquarters
2.7 Key Manufacturers Recombinant Limulus and Recombinant Factor C Reagent Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Recombinant Limulus and Recombinant Factor C Reagent
2.9 Recombinant Limulus and Recombinant Factor C Reagent Market Competitive Analysis
2.9.1 Recombinant Limulus and Recombinant Factor C Reagent Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Limulus and Recombinant Factor C Reagent Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Limulus and Recombinant Factor C Reagent as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Recombinant Limulus Reagent
3.1.2 Recombinant Factor C
3.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type
3.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Type (2020-2031)
3.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Type (%) (2020-2031)
3.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type
3.3.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Type (2020-2031)
3.3.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Type (%) (2020-2031)
3.4 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Medical Devices
4.1.3 Others
4.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application
4.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Application (2020-2031)
4.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Application (%) (2020-2031)
4.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application
4.3.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Application (2020-2031)
4.3.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Application (%) (2020-2031)
4.4 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region
5.1.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2020-2025)
5.1.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2026-2031)
5.1.4 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (%), (2020-2031)
5.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region
5.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2020-2025)
5.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2026-2031)
5.2.4 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (%), (2020-2031)
5.3 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
5.4.2 North America Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
5.5.2 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
5.6.2 Asia Pacific Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
5.7.2 South America Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
5.8.2 Middle East & Africa Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value and Sales Volume
6.2.1 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
6.2.2 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
6.3.2 United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
6.4.2 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
6.5.2 China Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
6.5.3 China Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
6.6.2 Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
6.7.2 South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
6.8.2 Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
6.9.2 India Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
6.9.3 India Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Lonza
7.1.1 Lonza Company Information
7.1.2 Lonza Introduction and Business Overview
7.1.3 Lonza Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Lonza Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
7.1.5 Lonza Recent Development
7.2 Biomerieux
7.2.1 Biomerieux Company Information
7.2.2 Biomerieux Introduction and Business Overview
7.2.3 Biomerieux Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Biomerieux Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
7.2.5 Biomerieux Recent Development
7.3 Associates of Cape Cod (ACC)
7.3.1 Associates of Cape Cod (ACC) Company Information
7.3.2 Associates of Cape Cod (ACC) Introduction and Business Overview
7.3.3 Associates of Cape Cod (ACC) Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Associates of Cape Cod (ACC) Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
7.3.5 Associates of Cape Cod (ACC) Recent Development
7.4 FUJIFILM Wako
7.4.1 FUJIFILM Wako Company Information
7.4.2 FUJIFILM Wako Introduction and Business Overview
7.4.3 FUJIFILM Wako Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 FUJIFILM Wako Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
7.4.5 FUJIFILM Wako Recent Development
7.5 Xiamen Bioendo Technology
7.5.1 Xiamen Bioendo Technology Company Information
7.5.2 Xiamen Bioendo Technology Introduction and Business Overview
7.5.3 Xiamen Bioendo Technology Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Xiamen Bioendo Technology Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
7.5.5 Xiamen Bioendo Technology Recent Development
7.6 Rhino Bio
7.6.1 Rhino Bio Company Information
7.6.2 Rhino Bio Introduction and Business Overview
7.6.3 Rhino Bio Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Rhino Bio Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
7.6.5 Rhino Bio Recent Development
8 Industry Chain Analysis
8.1 Recombinant Limulus and Recombinant Factor C Reagent Industrial Chain
8.2 Recombinant Limulus and Recombinant Factor C Reagent Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Recombinant Limulus and Recombinant Factor C Reagent Sales Model
8.5.2 Sales Channel
8.5.3 Recombinant Limulus and Recombinant Factor C Reagent Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer